HYBIO PHARMACEUTICAL CO. LTD.

Another API of Hybio Wuhan site, Octreotide Acetate, has passed the evaluation of Chinese NMPA! This API can be used in FDF commercial production for marketing. Great work for our Wuhan team! For their unremitting efforts since the operation of the site in 2019! We look forward to have more approvals soon. EU CEP is ready too! Your inquiries are welcome as always!

We welcome your visit at our booth 121A95! Look forward to our connection and cooperation soon!

Autumn is a season of harvest! Another API of Hybio Wuhan site, Desmopressin Acetate, has passed the evaluation of Chinese NMPA! This means that this API can be used in the FDF commercial production for marketing. Though our Wuhan site (a dedicated peptide API site) started running since 2019, our unremitting efforts has been paid off by harvesting more and more API approvals, nationally and worldwide. We expect more good news in September and welcome your inquiry as always!

Hybio Atosiban Acetate Injection has passed the Consistency Evaluation of the Quality and Efficacy of Generic Drugs by Chinese NMPA! Hybio has become the peptide pharma owning the largest number of Consistency-approved peptide FDFs in China. And we will continue devoting ourselves to deliver the best quality drug to the society. The other 5 peptide FDFs are: Terlipressin for injection, Carbetocin injection, Eptifibatide injection, Thymalfasin for injection and Somatostatin for injection. Moreover, Hybio peptide API is available for global customers and we heartily welcome your inquiry.

One last exciting news for year 2021! On December 28th, Hybio Terlipressin for Injection, as the first drug of its kind, has passed the Consistency Evaluation of the Quality and Efficacy of Generic Drugs by Chinese NMPA! It is Hybio's 6th drug to pass the NMPA evaluation for the year 2021. The other 5 are Somatostatin for Injection, Carbetocin Injection, Eptifibatide Injection, Thymalfasin for Injection, Pramipexole hydrochloride sustained release tablets. Also, Hybio Terlipressin API with approved CEP (CEP 2020-319-P01) is available for global customers.

Great news! On November 5th, Hybio Somatostatin for Injection has become the first of its kind approved by NMPA for the Consistency Evaluation of the Quality and Efficacy of Generic Drugs! It is Hybio’s fifth drug to pass the NMPA evaluation this year. The other four are Carbetocin Injection, Eptifibatide Injection, Thymalfasin for Injection, Pramipexole hydrochloride sustained release tablets. We heartily welcome your inquiry and propose for cooperation.

On November 18, Hybio obtained the CEP certificate from EDQM for our drug substance Oxytocin. Oxytocin is cyclic peptide with 9 amino acids. It is an important hormone that is used to induce labor or strengthen uterine contractions, to control bleeding after childbirth, or to stimulate uterine contractions in a woman with an incomplete or threatened miscarriage. Hybio offers high quality DS Oxytocin to make its contribution in guarding people’s health and life. We heartily welcome your inquiry on the product and collaboration.